Yea the presentations used to say possible FDA approval in 2026 based on phase 2 results. I'd say that's now 2027 with the 6-9 month delay.
So I take it that there is an interim readout for a certain number of patients that corresponds to the phase 2 of the phase 2/3 trial?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.69M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $30.84K | 173.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 821087 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 6102 | 2 |
View Market Depth
| Last trade - 12.49pm 28/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |